Promising Interim Results for Phase 2 Trial

Genkyotex “published interim efficacy results today, GKT831 met both it’s primary and secondary endpoints in the Phase II PBC trial! A big thank you to the patients who participate in the study and their doctors. And congrats to the Genkyotex team.” Read results here.